TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first ...

ALLEGAN, Mich., Oct. 13, 2023 /PRNewswire/ -- Padagis today announced the launch of Brinzolamide Ophthalmic Suspension with Competitive Generic Therapy (CGT) exclusivity (generic equivalent to the ...

Teva is launching brinzolamide ophthalmic suspension, 1%. The product is the first-to-market generic of Novartis' Azopt (brinzolamide ophthalmic suspension). It is used to treat elevated pressure ...

Please provide your email address to receive an email when new articles are posted on . Teva Pharmaceuticals USA has launched the first generic version of Azopt in ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire exclusive U.S.